table of contents
Latent autoimmune diabetes in adults (LADA) is an often-misunderstood form of diabetes that shares characteristics of both type 1 and type 2 diabetes. Sometimes referred to as “type 1.5 diabetes,” LADA develops in adulthood and progresses gradually, often leading to misdiagnosis as type 2 diabetes. Unlike type 2 diabetes, LADA is an autoimmune condition, meaning the immune system attacks insulin-producing beta cells in the pancreas. Over time, this leads to insulin dependence.
In this article, we will explore the causes, symptoms, diagnosis, and treatment of LADA and why early detection is critical for effective management.
What Causes LADA?
LADA is an autoimmune disease, meaning the body’s immune system mistakenly attacks its own insulin-producing cells. This process occurs more slowly than in classic type 1 diabetes, where beta cell destruction happens rapidly, often in childhood.
- Autoimmune Factors
Research has identified autoantibodies—immune markers that attack the pancreas—in people with LADA. A study published in Diabetes found that 5–10% of adults diagnosed with type 2 diabetes actually have LADA, as they test positive for pancreatic autoantibodies.
Dr. Jerry Palmer, an endocrinologist at the University of Washington, explains:
“LADA is an autoimmune disorder that progresses over time. Many people are initially diagnosed with type 2 diabetes, but as their insulin production declines, it becomes clear that they have an autoimmune form of the disease.”
- Genetic Susceptibility
LADA shares genetic similarities with both type 1 and type 2 diabetes. Studies have found that people with certain HLA gene variations—commonly linked to type 1 diabetes—are at higher risk of developing LADA.
- Environmental Triggers
Viruses, stress, and lifestyle factors may trigger the onset of LADA in genetically predisposed individuals. While obesity and insulin resistance are common in type 2 diabetes, LADA patients are often leaner, suggesting different underlying mechanisms.
Symptoms of LADA
LADA symptoms develop gradually, unlike classic type 1 diabetes, which can appear suddenly. Common symptoms include:
- Increased thirst (polydipsia)
- Frequent urination (polyuria)
- Unexplained weight loss
- Fatigue and weakness
- Blurred vision
- Slow-healing wounds and infections
Since these symptoms overlap with type 2 diabetes, many adults with LADA are initially prescribed oral medications, such as metformin, but eventually require insulin therapy as their condition progresses.
How Is LADA Diagnosed?
Diagnosing LADA requires distinguishing it from type 2 diabetes. Unfortunately, many healthcare providers do not routinely test for autoimmune markers in adults diagnosed with diabetes.
Key Diagnostic Tests:
- Autoantibody Tests: Detecting GAD (glutamic acid decarboxylase) autoantibodies is a hallmark of LADA. Other antibodies, such as IA-2 and ZnT8, may also be present.
- C-Peptide Test: Measures insulin production levels. LADA patients often have lower C-peptide levels than those with type 2 diabetes.
- Blood Sugar and A1C Levels: While elevated glucose and A1C levels indicate diabetes, they do not differentiate between LADA and type 2 diabetes.
A study published in The Journal of Clinical Endocrinology & Metabolism found that up to 10% of adults diagnosed with type 2 diabetes could have LADA, highlighting the importance of autoantibody testing.
Dr. Anne Peters, an endocrinologist at the University of Southern California, emphasizes:
“If an adult patient with a type 2 diabetes diagnosis is lean, has rapidly worsening blood sugar control, or requires insulin within a few years, LADA should be considered as a possible diagnosis.”
How Is LADA Treated?
Since LADA is an autoimmune condition, its treatment differs from type 2 diabetes management.
- Early Insulin Therapy
Unlike type 2 diabetes, where oral medications can be effective for years, LADA patients typically require insulin sooner. Delaying insulin therapy can accelerate beta cell destruction.
Dr. David Leslie, a diabetes researcher at the University of London, explains:
“Early insulin therapy may help preserve remaining beta cell function and slow disease progression in LADA patients.”
- Personalized Blood Sugar Monitoring
Since LADA progresses differently in each patient, continuous glucose monitoring (CGM) devices, such as Glucofit, can help track blood sugar trends and optimize treatment.
A study in Diabetes Care found that LADA patients who used CGMs had better blood sugar control and fewer complications.
- Lifestyle Modifications
While lifestyle changes alone cannot stop LADA progression, a balanced diet and regular exercise support metabolic health.
✅ Low-Glycemic Diet: Focus on whole foods, fiber, and lean proteins to stabilize blood sugar.
✅ Regular Exercise: Physical activity improves insulin sensitivity and helps regulate glucose levels.
✅ Stress Management: Chronic stress can impact blood sugar levels, making relaxation techniques beneficial.
LADA vs. Type 1 and Type 2 Diabetes: What’s the Difference?
| Feature | Type 1 Diabetes | LADA (Type 1.5) | Type 2 Diabetes |
| Onset Age | Childhood/Adolescence | Adulthood (Usually 30+) | Adulthood (Usually 40+) |
| Cause | Autoimmune | Autoimmune | Insulin resistance |
| Progression | Rapid beta cell destruction | Gradual beta cell destruction | Slow insulin resistance development |
| Insulin Need | Immediate | Delayed but eventual | Variable, often later in disease |
| Weight | Usually normal or underweight | Often normal or slightly overweight | Often overweight or obese |
| Autoantibodies | Present | Present | Absent |
Why Early Diagnosis of LADA Matters
Misdiagnosing LADA as type 2 diabetes can lead to inappropriate treatment. Many LADA patients start on oral medications like metformin, which may not be effective as their insulin production declines.
According to a study published in Diabetologia, LADA patients who receive early insulin therapy have better long-term outcomes and slower disease progression.
Dr. Richard Oram, a diabetes researcher at the University of Exeter, emphasizes:
“LADA is often misdiagnosed as type 2 diabetes, leading to delays in appropriate treatment. Identifying LADA early allows for better disease management and improved patient outcomes.”
Conclusion
LADA is a unique form of diabetes that combines features of both type 1 and type 2 diabetes. Because it progresses slowly, many adults are initially misdiagnosed with type 2 diabetes. However, recognizing LADA early and initiating appropriate treatment—especially insulin therapy—can help preserve beta cell function and improve long-term health outcomes.
For those with diabetes who experience worsening blood sugar control despite oral medications, testing for LADA is crucial. Tools like Glucofit can provide real-time blood sugar insights, helping patients and healthcare providers make informed treatment decisions.
If you suspect you might have LADA or have been struggling with blood sugar control, consider speaking with your doctor about additional testing. Early intervention is key to better diabetes management.
Would you like to learn more about how Glucofit can help track and optimize your blood sugar? Stay informed and take control of your health today!
